Oxurion receives a transparency notification from Atlas Special Opportunities II LLC

Oxurion NV, a company based in Leuven, Belgium, announced that it received a transparency notification from Atlas Special Opportunities II LLC on January 23, 2026. This communication indicates that Atlas held 6,337,343 shares out of a total of 70,098,394 shares outstanding as of January 22, 2026, thus falling below the 10% threshold due to the sale of voting instruments.

In accordance with Belgian transparency legislation, Oxurion is complying with disclosure requirements to reflect significant changes in its shareholdings. This notification comes as the company pursues its acquisition strategy in the European pharmaceutical sector. It underscores Oxurion's commitment to clear and regulated communication with its partners and investors.